真实世界数据挑战雷达:关于使用真实世界数据的挑战和风险的回顾。

Q1 Computer Science Digital Biomarkers Pub Date : 2021-06-24 eCollection Date: 2021-05-01 DOI:10.1159/000516178
Frank Grimberg, Petra Maria Asprion, Bettina Schneider, Enkelejda Miho, Lmar Babrak, Ali Habbabeh
{"title":"真实世界数据挑战雷达:关于使用真实世界数据的挑战和风险的回顾。","authors":"Frank Grimberg,&nbsp;Petra Maria Asprion,&nbsp;Bettina Schneider,&nbsp;Enkelejda Miho,&nbsp;Lmar Babrak,&nbsp;Ali Habbabeh","doi":"10.1159/000516178","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>The life science industry has a strong interest in real-world data (RWD), a term that is currently being used in many ways and with varying definitions depending on the source. In this review article, we provide a summary overview of the challenges and risks regarding the use of RWD and its translation into real-world evidence and provide a classification and visualization of RWD challenges by means of the RWD Challenges Radar.</p><p><strong>Summary: </strong>Based on a systematic literature search, we identified 3 types of challenges - organizational, technological, and people-based - that must be addressed when deriving evidence from RWD to be used in drug approval and other applications. It further demonstrates that numerous different aspects, for example, related to the application field and the associated industry, must be considered. A key finding in our review is that the regulatory landscape must be carefully assessed before utilizing RWD.</p><p><strong>Key messages: </strong>Establishing awareness and insight into the challenges and risks regarding the use of RWD will be key to taking full advantage of the RWD potential. As a result of this review, an \"RWD Challenges Radar\" will support the establishment of awareness by providing a comprehensive overview of the relevant aspects to be considered when employing RWD.</p>","PeriodicalId":11242,"journal":{"name":"Digital Biomarkers","volume":"5 2","pages":"148-157"},"PeriodicalIF":0.0000,"publicationDate":"2021-06-24","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1159/000516178","citationCount":"10","resultStr":"{\"title\":\"The Real-World Data Challenges Radar: A Review on the Challenges and Risks regarding the Use of Real-World Data.\",\"authors\":\"Frank Grimberg,&nbsp;Petra Maria Asprion,&nbsp;Bettina Schneider,&nbsp;Enkelejda Miho,&nbsp;Lmar Babrak,&nbsp;Ali Habbabeh\",\"doi\":\"10.1159/000516178\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><strong>Background: </strong>The life science industry has a strong interest in real-world data (RWD), a term that is currently being used in many ways and with varying definitions depending on the source. In this review article, we provide a summary overview of the challenges and risks regarding the use of RWD and its translation into real-world evidence and provide a classification and visualization of RWD challenges by means of the RWD Challenges Radar.</p><p><strong>Summary: </strong>Based on a systematic literature search, we identified 3 types of challenges - organizational, technological, and people-based - that must be addressed when deriving evidence from RWD to be used in drug approval and other applications. It further demonstrates that numerous different aspects, for example, related to the application field and the associated industry, must be considered. A key finding in our review is that the regulatory landscape must be carefully assessed before utilizing RWD.</p><p><strong>Key messages: </strong>Establishing awareness and insight into the challenges and risks regarding the use of RWD will be key to taking full advantage of the RWD potential. As a result of this review, an \\\"RWD Challenges Radar\\\" will support the establishment of awareness by providing a comprehensive overview of the relevant aspects to be considered when employing RWD.</p>\",\"PeriodicalId\":11242,\"journal\":{\"name\":\"Digital Biomarkers\",\"volume\":\"5 2\",\"pages\":\"148-157\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2021-06-24\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://sci-hub-pdf.com/10.1159/000516178\",\"citationCount\":\"10\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Digital Biomarkers\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.1159/000516178\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"2021/5/1 0:00:00\",\"PubModel\":\"eCollection\",\"JCR\":\"Q1\",\"JCRName\":\"Computer Science\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Digital Biomarkers","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1159/000516178","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2021/5/1 0:00:00","PubModel":"eCollection","JCR":"Q1","JCRName":"Computer Science","Score":null,"Total":0}
引用次数: 10

摘要

背景:生命科学行业对真实世界数据(RWD)有着浓厚的兴趣,这个术语目前被以多种方式使用,并且根据来源有不同的定义。在这篇综述文章中,我们总结了RWD的挑战和风险,并将其转化为现实世界的证据,并通过RWD挑战雷达提供了RWD挑战的分类和可视化。摘要:基于系统的文献检索,我们确定了在从RWD获得用于药物审批和其他应用的证据时必须解决的3种挑战——组织、技术和以人为本。它进一步表明,必须考虑许多不同的方面,例如与应用领域和相关工业有关的方面。我们回顾的一个关键发现是,在使用RWD之前,必须仔细评估监管环境。关键信息:要充分利用随钻作业的潜力,关键是要认识和洞察随钻作业的挑战和风险。通过这一审查,“RWD挑战雷达”将通过提供在使用RWD时需要考虑的相关方面的全面概述来支持建立意识。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
The Real-World Data Challenges Radar: A Review on the Challenges and Risks regarding the Use of Real-World Data.

Background: The life science industry has a strong interest in real-world data (RWD), a term that is currently being used in many ways and with varying definitions depending on the source. In this review article, we provide a summary overview of the challenges and risks regarding the use of RWD and its translation into real-world evidence and provide a classification and visualization of RWD challenges by means of the RWD Challenges Radar.

Summary: Based on a systematic literature search, we identified 3 types of challenges - organizational, technological, and people-based - that must be addressed when deriving evidence from RWD to be used in drug approval and other applications. It further demonstrates that numerous different aspects, for example, related to the application field and the associated industry, must be considered. A key finding in our review is that the regulatory landscape must be carefully assessed before utilizing RWD.

Key messages: Establishing awareness and insight into the challenges and risks regarding the use of RWD will be key to taking full advantage of the RWD potential. As a result of this review, an "RWD Challenges Radar" will support the establishment of awareness by providing a comprehensive overview of the relevant aspects to be considered when employing RWD.

求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
Digital Biomarkers
Digital Biomarkers Medicine-Medicine (miscellaneous)
CiteScore
10.60
自引率
0.00%
发文量
12
审稿时长
23 weeks
期刊最新文献
The Imperative of Voice Data Collection in Clinical Trials. eHealth and mHealth in Antimicrobial Stewardship Programs. Detecting Longitudinal Trends between Passively Collected Phone Use and Anxiety among College Students. Video Assessment to Detect Amyotrophic Lateral Sclerosis. Digital Vocal Biomarker of Smoking Status Using Ecological Audio Recordings: Results from the Colive Voice Study.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1